Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
- December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
- 2011 -
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
December 2011 - 17 products
L
IP
Meropenem Fresenius i.v. 500 mg
10 x 500 mg
111.75
137.95
10 %
Dry substance: Meropenemum 500 mg
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
L
IP
Meropenem Fresenius i.v. 1 g
10 x 1 g
215.52
250.80
10 %
Dry substance: Meropenemum 1000 mg
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
CI
Tamsulosin T-Mepha retard
10 Tablet(s)
4.59
14.25
10 %
Delayed release tablets: Tamsulosini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Tamsulosin T-Mepha retard
30 Tablet(s)
10.28
27.60
10 %
Delayed release tablets: Tamsulosini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Tamsulosin T-Mepha retard
100 Tablet(s)
33.06
52.35
10 %
Delayed release tablets: Tamsulosini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Orlistat Sandoz
42 Capsule(s)
23.93
42.45
10 %
Capsules: Orlistatum 120 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Orlistat Sandoz
84 Capsule(s)
46.31
66.80
10 %
Capsules: Orlistatum 120 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
PP
Optava Unit Dose
30 1 unidose(s) à 0.4 ml
9.19
16.95
10 %
Eye drops: Carmellosum Natricum 5 mg/ml
AbbVie AG
●
D / SL
FB
G
IP
CI
Insulin NovoNordisk
NovoRapid FlexTouch
5 x 3 ml
36.93
56.60
10 %
Injection solution: Insulinum Aspartum 100 UI/ml
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
XGEVA 120 mg
Durchstechflasche(n)
379.81
429.50
10 %
Injection solution: Denosumabum 120mg / 1.7ml
Amgen Switzerland AG
A / SL
FB
G
L
IP
PP
Nulojix 250 mg
391.50
442.20
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belataceptum 250 mg
Bristol-Myers Squibb SA
A / SL
FB
G
L
IP
PP
Nulojix 250 mg
2
783.00
868.00
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belataceptum 250 mg
Bristol-Myers Squibb SA
A / SL
FB
G
IP
XGEVA 120 mg
4 Durchstechflasche(n)
PR
PR
k.A.
Injection solution: Denosumabum 120mg / 1.7ml
Amgen Switzerland AG
A
FB
G
Ph
Fisherman's Friend Cassis
Halspastillen
25 g
PR
PR
k.A.
Lozenges: Levomentholum 6.038 mg
Ricola AG
E
FB
G
Ph
Fisherman's Friend Cassis
Halspastillen
2 x 25 g
PR
PR
k.A.
Lozenges: Levomentholum 6.038 mg
Ricola AG
E
FB
G
IP
CI
Mebu-Cherry
24 Tablet(s)
PR
PR
k.A.
Lozenges: 3 Active Agents
Spirig HealthCare AG
D / LPPV
FB
G
IP
CI
Mebu-Lemon
24 Tablet(s)
PR
PR
k.A.
Lozenges: 3 Active Agents
Spirig HealthCare AG
D / LPPV
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
